These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

137 related articles for article (PubMed ID: 21842255)

  • 1. Acute myocardial infarction in a teenager due to Adderall XR.
    Sylvester AL; Agarwala B
    Pediatr Cardiol; 2012 Jan; 33(1):155-7. PubMed ID: 21842255
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Not acute myocardial infarction in a teenager due to Adderall XR.
    Rosenthal E
    Pediatr Cardiol; 2012 Apr; 33(4):679. PubMed ID: 22354226
    [No Abstract]   [Full Text] [Related]  

  • 3. Acute myocardial infarction induced by concurrent use of adderall and alcohol in an adolescent.
    Sharma J; de Castro C; Chatterjee P; Pinto R
    Pediatr Emerg Care; 2013 Jan; 29(1):84-8. PubMed ID: 23283274
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Myocardial infarction in an adolescent taking Adderall.
    Gandhi PJ; Ezeala GU; Luyen TT; Tu TC; Tran MT
    Am J Health Syst Pharm; 2005 Jul; 62(14):1494-7. PubMed ID: 15998931
    [No Abstract]   [Full Text] [Related]  

  • 5. Adderall XR: long acting stimulant for single daily dosing.
    Sallee FR; Smirnoff AV
    Expert Rev Neurother; 2004 Nov; 4(6):927-34. PubMed ID: 15853519
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Myocardial infarction associated with adderall XR and alcohol use in a young man.
    Jiao X; Velez S; Ringstad J; Eyma V; Miller D; Bleiberg M
    J Am Board Fam Med; 2009; 22(2):197-201. PubMed ID: 19264944
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Acute myocardial infarction related to methylphenidate for adult attention deficit disorder.
    Thompson J; Thompson JR
    J Emerg Med; 2010 Jan; 38(1):18-21. PubMed ID: 18024065
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Safety, efficacy and extended duration of action of mixed amphetamine salts extended-release capsules for the treatment of ADHD.
    Weisler RH
    Expert Opin Pharmacother; 2005 Jun; 6(6):1003-18. PubMed ID: 15952928
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Efficacy and safety of mixed amphetamine salts extended release (Adderall XR) in the management of attention-deficit/hyperactivity disorder in adolescent patients: a 4-week, randomized, double-blind, placebo-controlled, parallel-group study.
    Spencer TJ; Wilens TE; Biederman J; Weisler RH; Read SC; Pratt R
    Clin Ther; 2006 Feb; 28(2):266-79. PubMed ID: 16678648
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Acute, sustained chorea in children after supratherapeutic dosing of amphetamine-derived medications.
    Ford JB; Albertson TE; Owen KP; Sutter ME; McKinney WB
    Pediatr Neurol; 2012 Sep; 47(3):216-8. PubMed ID: 22883290
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Questions about Adderall XR.
    Biron P; Mintzes B; Lexchin J
    CMAJ; 2006 Apr; 174(9):1303-4. PubMed ID: 16636331
    [No Abstract]   [Full Text] [Related]  

  • 12. Retrospective comparison of Adderall and methylphenidate in the treatment of attention deficit hyperactivity disorder.
    Grcevich S; Rowane WA; Marcellino B; Sullivan-Hurst S
    J Child Adolesc Psychopharmacol; 2001; 11(1):35-41. PubMed ID: 11322743
    [TBL] [Abstract][Full Text] [Related]  

  • 13. An update on central nervous system stimulant formulations in children and adolescents with attention-deficit/hyperactivity disorder.
    Chavez B; Sopko MA; Ehret MJ; Paulino RE; Goldberg KR; Angstadt K; Bogart GT
    Ann Pharmacother; 2009 Jun; 43(6):1084-95. PubMed ID: 19470858
    [TBL] [Abstract][Full Text] [Related]  

  • 14. A comparison of ritalin and adderall: efficacy and time-course in children with attention-deficit/hyperactivity disorder.
    Pelham WE; Aronoff HR; Midlam JK; Shapiro CJ; Gnagy EM; Chronis AM; Onyango AN; Forehand G; Nguyen A; Waxmonsky J
    Pediatrics; 1999 Apr; 103(4):e43. PubMed ID: 10103335
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Differential effectiveness of methylphenidate and Adderall in school-age youths with attention-deficit/hyperactivity disorder.
    Manos MJ; Short EJ; Findling RL
    J Am Acad Child Adolesc Psychiatry; 1999 Jul; 38(7):813-9. PubMed ID: 10405498
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Placebo-controlled evaluation of amphetamine mixture-dextroamphetamine salts and amphetamine salts (Adderall): efficacy rate and side effects.
    Ahmann PA; Theye FW; Berg R; Linquist AJ; Van Erem AJ; Campbell LR
    Pediatrics; 2001 Jan; 107(1):E10. PubMed ID: 11134474
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Long-term tolerability and effectiveness of once-daily mixed amphetamine salts (Adderall XR) in children with ADHD.
    McGough JJ; Biederman J; Wigal SB; Lopez FA; McCracken JT; Spencer T; Zhang Y; Tulloch SJ
    J Am Acad Child Adolesc Psychiatry; 2005 Jun; 44(6):530-8. PubMed ID: 15908835
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Pharmacokinetics of SLI381 (ADDERALL XR), an extended-release formulation of Adderall.
    McGough JJ; Biederman J; Greenhill LL; McCracken JT; Spencer TJ; Posner K; Wigal S; Gornbein J; Tulloch S; Swanson JM
    J Am Acad Child Adolesc Psychiatry; 2003 Jun; 42(6):684-91. PubMed ID: 12921476
    [TBL] [Abstract][Full Text] [Related]  

  • 19. A comparison of morning-only and morning/late afternoon Adderall to morning-only, twice-daily, and three times-daily methylphenidate in children with attention-deficit/hyperactivity disorder.
    Pelham WE; Gnagy EM; Chronis AM; Burrows-MacLean L; Fabiano GA; Onyango AN; Meichenbaum DL; Williams A; Aronoff HR; Steiner RL
    Pediatrics; 1999 Dec; 104(6):1300-11. PubMed ID: 10585981
    [TBL] [Abstract][Full Text] [Related]  

  • 20. SLI381: a long-acting psychostimulant preparation for the treatment of attention-deficit hyperactivity disorder.
    Grcevich S
    Expert Opin Investig Drugs; 2001 Nov; 10(11):2003-11. PubMed ID: 11772303
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 7.